Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|October 4, 2016
Varenicline improves motor and cognitive symptoms in early Huntington's diseaseAilsa L McGregor, Jo Dysart, Malcolm D Tingle, et al.
Clinical and Experimental Pharmacology & Physiology|August 2, 2008
Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitroDeanna N Bell, Johnson J Liu, Malcolm D Tingle, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 30, 2024
A pharmacokinetic framework describing antibiotic adsorption to cardiopulmonary bypass devicesConor J O'Hanlon, Nick Holford, Brian J Anderson, et al.
Toxicology|September 7, 2007
Hepatic nitroreduction, toxicity and toxicokinetics of the anti-tumour prodrug CB 1954 in mouse and ratMagdalene Huen Yin Tang, Nuala A Helsby, Michael A Goldthorpe, et al.
Toxicology and Applied Pharmacology|October 11, 2003
3'-azido-3'-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placentaAbby C Collier, Rachel J A Helliwell, Jeffrey A Keelan, et al.
Bioorganic & Medicinal Chemistry|March 8, 2014
Synthesis and methemoglobinemia-inducing properties of benzocaine isosteres designed as humane rodenticidesDaniel Conole, Thorsten M Beck, Morgan Jay-Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2004
Human placental glucuronidation and transport of 3'azido-3'-deoxythymidine and uridine diphosphate glucuronic acidAbby C Collier, Jeffrey A Keelan, Pierre E Van Zijl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugsNuala A Helsby, Michael A Goldthorpe, Magdalene H Y Tang, et al.
Biochemical Pharmacology|February 21, 2002
UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at termAbby C Collier, Natalie A Ganley, Malcolm D Tingle, et al.
British Journal of Clinical Pharmacology|December 24, 2010
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivationNuala A Helsby, Chung-Yee Hui, Michael A Goldthorpe, et al.
Pageof 4